The Efficacy of Axillary Reverse Mapping for the Prevention of Lymphedema
- PMID: 37619219
- DOI: 10.1177/00031348231198103
The Efficacy of Axillary Reverse Mapping for the Prevention of Lymphedema
Abstract
Background: Lymphedema (LE) is the most notable complication of axillary surgery. The axillary reverse mapping (ARM) technique was created to decrease LE. This study aims to evaluate a single surgeon's experience with ARM in patients undergoing sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) for breast cancer.
Methods: We retrospectively analyzed patients who underwent SLNB or ALND. Tumor characteristics and treatments received were evaluated. Surgical intervention and use of ARM were compared to assess LE rates. A subgroup analysis was also performed of patients who underwent NAC.
Results: LE was initially reported in 7.1% (n = 10) of patients; 3.3% (n = 4) with SLNB and 35% (n = 6) with ALND. At initial follow-up, LE was reported 16.4% more often in patients who underwent ALND with no ARM, and 38.8% more often in patients who underwent ALND plus ARM. An increased risk of LE was found in patients treated with ALND (OR = 16.0, P < .001). All patients who underwent ARM were 12.75% more likely to develop LE if they received NAC (P < .05). Patients in the ALND group who also received NAC were more likely to undergo ARM as compared with patients in the SLNB group (P < .01).
Discussion: Our study showed that ARM failed to decrease the incidence of LE. Until better surgical outcomes are shown for the prevention of LE using ARM, other approaches should be utilized. However, larger prospective studies are needed to evaluate ARM.
Keywords: axillary lymph node dissection; axillary surgery; breast cancer; lymphedema; sentinel lymph node biopsy.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.World J Surg Oncol. 2020 Jun 1;18(1):118. doi: 10.1186/s12957-020-01886-9. World J Surg Oncol. 2020. PMID: 32482174 Free PMC article.
-
Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.Lymphology. 2004 Jun;37(2):73-91. Lymphology. 2004. PMID: 15328760
-
Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?Ann Surg. 2017 May;265(5):987-992. doi: 10.1097/SLA.0000000000001778. Ann Surg. 2017. PMID: 27163955 Clinical Trial.
-
Axillary reverse mapping (ARM): where to go.Breast Cancer. 2019 Jan;26(1):1-10. doi: 10.1007/s12282-018-0886-0. Epub 2018 Jun 30. Breast Cancer. 2019. PMID: 29961238 Review.
-
Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.Ann Surg. 2023 Apr 1;277(4):572-580. doi: 10.1097/SLA.0000000000005671. Epub 2022 Aug 10. Ann Surg. 2023. PMID: 35946806 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical